Comparison of the daytime sleep and performance effects of zolpidem versus triazolam
β Scribed by Thomas J. Balkin; Vincent M. O'Donnell; Nancy Wesensten; Una McCann; Gregory Belenky
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 790 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rebound insomnia is a transient intense worsening of sleep usually appearing within 3 days from the abrupt discontinuation of benzodiazepines (mainly short-acting), following long term use and abuse of these hypnotics. Zolpidem is an imidazopyridine, that binds selectively at mi-receptor subtypes wi
The effects of a short-acting benzodiazepine hypnotic, triazolam (0.5 mg), on sleep, performance, and arousal threshold were assessed in 20 male poor sleepers (age 21 +/- 2.37 years). Following in a laboratory screening night, all subjects received placebo for 3 nights (single-blind), ten received t